Medicinal product name Erivedge
Pharmaceutical form Capsule, hard
Strength 150 mg 
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresIzglītojošie materiāli ārstam Izglītojošie materiāli ārstam
Izglītojošie materiāli pacientam Izglītojošie materiāli pacientam
ATC code L01XJ01 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N28
(150 mg)
HDPE bottle    EU/1/13/848/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/13/848/001
Date of authorisation Jul 12, 2013
Marketing authorisation holder, country Roche Registration GmbH, Germany